Page last updated: 2024-08-24

ginkgolide b and cycloheximide

ginkgolide b has been researched along with cycloheximide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cordeiro, RS; e Silva, PM; Faria Neto, HC; Martins, MA; Vargaftig, BB1
Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

3 other study(ies) available for ginkgolide b and cycloheximide

ArticleYear
Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: Animals; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Cycloheximide; Dactinomycin; Dexamethasone; Diterpenes; Drug Stability; Eosinophils; Ginkgolides; Lactones; Male; Platelet Activating Factor; Pleura; Rats; Rats, Inbred Strains; Temperature

1991
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
    The Journal of clinical investigation, 1997, Apr-15, Volume: 99, Issue:8

    Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles

1997
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012